IVAC MUTANOME Phase I Clinical Trial
Clinical trial NCT02035956 · COMPLETED
Trial details
- NCT number
- NCT02035956
- Sponsor
- BioNTech RNA Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2017-02-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.